Trials / Withdrawn
WithdrawnNCT03395925
Evaluation of the Thyroid Volume After Radiofrequency Ablation of Thyroid Nodules and Recurrent Thyroid
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Olympus Surgical Technologies Europe · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Thyroid nodules are among the common alterations of the thyroid. Depending on the detection method the prevalence is between 20% and 50%, whereas the incidence increases with improvement of ultrasonic technology. The CelonPro Surge bipolar coagulation electrode operated with the compatible power control unit and compatible tube pump is indicated for ablation and coagulation of soft tissue, including thermal inactivation and/or volume reduction of locally defined tissue areas, such as tumors and metastases. The primary objective of the study is to assess the influence of radiofrequency ablation due to thyroid volume after 24 hours, 3 months, 6 months and 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Celon Pro Surge | bipolar coagulation electrode intended for tissue heating |
Timeline
- Start date
- 2017-11-10
- Primary completion
- 2021-10-30
- Completion
- 2022-01-30
- First posted
- 2018-01-10
- Last updated
- 2022-12-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03395925. Inclusion in this directory is not an endorsement.